• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国的日本脑炎免疫接种:一项政策分析。

Immunization against Japanese encephalitis in China: a policy analysis.

作者信息

Liu Wei, Clemens John D, Yang Jin-ye, Xu Zhi Yi

机构信息

International Vaccine Institute, P.O. Box 14, Kwanak, Seoul 151-600, Republic of Korea.

出版信息

Vaccine. 2006 Jun 12;24(24):5178-82. doi: 10.1016/j.vaccine.2006.04.006. Epub 2006 Apr 24.

DOI:10.1016/j.vaccine.2006.04.006
PMID:16697091
Abstract

This study examined the impact of Japanese encephalitis (JE) immunization policies on disease trends in China. Through a document review and key source interviews in eight provinces, the study found, JE immunizations were provided via a combination of fee-for-service and government funding. Unequal government funding and unbalanced economic development led to variation in JE incidence levels between provinces. Government support of low-fee JE immunization, has led to nationwide decline of JE incidence by >90%; however, greater reliance on user fees and market mechanisms in rural areas has limited the provision of JE and other childhood immunizations to poor rural children.

摘要

本研究考察了日本脑炎(乙脑)免疫政策对中国疾病流行趋势的影响。通过对八个省份的文献回顾和关键信息源访谈,研究发现,乙脑免疫接种是通过收费服务和政府资助相结合的方式提供的。政府资助不均以及经济发展不平衡导致各省乙脑发病率存在差异。政府对低收费乙脑免疫接种的支持,已使全国乙脑发病率下降了90%以上;然而,农村地区对用户收费和市场机制的更大依赖,限制了向贫困农村儿童提供乙脑及其他儿童免疫接种服务。

相似文献

1
Immunization against Japanese encephalitis in China: a policy analysis.中国的日本脑炎免疫接种:一项政策分析。
Vaccine. 2006 Jun 12;24(24):5178-82. doi: 10.1016/j.vaccine.2006.04.006. Epub 2006 Apr 24.
2
An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.中国贵州省扩大免疫规划中使用乙型脑炎疫苗的经济学评价。
Vaccine. 2012 Aug 10;30(37):5569-77. doi: 10.1016/j.vaccine.2012.05.068. Epub 2012 Jun 12.
3
Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.印度尼西亚巴厘岛乙型脑炎(JE)免疫接种的成本效益
Vaccine. 2008 Aug 18;26(35):4456-60. doi: 10.1016/j.vaccine.2008.06.050. Epub 2008 Jul 3.
4
A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia.柬埔寨乙型脑炎疫苗的成本效益分析。
Vaccine. 2010 Jun 23;28(29):4593-9. doi: 10.1016/j.vaccine.2010.04.086. Epub 2010 May 14.
5
[Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].[海南省乙型脑炎的流行病学特征及相关影响因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 May;30(5):471-4.
6
A chimeric live attenuated vaccine against Japanese encephalitis.一种针对日本脑炎的嵌合减毒活疫苗。
Expert Rev Vaccines. 2004 Jun;3(3):243-8. doi: 10.1586/14760584.3.3.243.
7
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.通过被动转移针对ChimeriVax-JE实验性疫苗产生的血清来预防代表四种基因型的日本脑炎病毒株。
Vaccine. 2004 Sep 9;22(27-28):3722-6. doi: 10.1016/j.vaccine.2004.03.027.
8
Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.中国上海通过常规免疫控制日本脑炎的成本效益分析。
Bull World Health Organ. 2003;81(5):334-42. Epub 2003 Jul 7.
9
The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.鼠脑灭活中山株日本脑炎疫苗的效力——台湾30年经验的结果
Vaccine. 2006 Mar 24;24(14):2669-73. doi: 10.1016/j.vaccine.2005.10.054. Epub 2005 Nov 10.
10
Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.高效抗逆转录病毒治疗后免疫恢复的HIV感染儿童的日本脑炎疫苗接种
Vaccine. 2007 Nov 28;25(49):8257-61. doi: 10.1016/j.vaccine.2007.09.052. Epub 2007 Oct 11.

引用本文的文献

1
Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.SA 14-14-2 减毒活日本脑炎疫苗在缅甸的有效性。
Vaccines (Basel). 2021 May 31;9(6):568. doi: 10.3390/vaccines9060568.
2
Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis.减毒活疫苗接种与儿童期起病重症肌无力之间的分子和临床关系。
Ann Neurol. 2018 Sep;84(3):386-400. doi: 10.1002/ana.25267.
3
Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III.
日本脑炎病毒疫苗的福尔马林灭活改变了包膜蛋白结构域III中一个中和表位的抗原性和免疫原性。
PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004167. doi: 10.1371/journal.pntd.0004167. eCollection 2015 Oct.
4
Investigation of the genotype III to genotype I shift in Japanese encephalitis virus and the impact on human cases.日本脑炎病毒基因型III向基因型I转变的研究及其对人类病例的影响。
Virol Sin. 2015 Aug;30(4):277-89. doi: 10.1007/s12250-015-3621-4. Epub 2015 Aug 18.
5
Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam.越南国产鼠脑灭活乙型脑炎疫苗在越南北部的有效性。
PLoS Negl Trop Dis. 2012;6(12):e1952. doi: 10.1371/journal.pntd.0001952. Epub 2012 Dec 13.
6
Regional disparities in the burden of disease attributable to unsafe water and poor sanitation in China.中国因不安全饮用水和环境卫生差导致的疾病负担的区域差异。
Bull World Health Organ. 2012 Aug 1;90(8):578-87. doi: 10.2471/BLT.11.098343. Epub 2012 May 31.
7
A novel low-cost approach to estimate the incidence of Japanese encephalitis in the catchment area of three hospitals in Bangladesh.一种新的低成本方法来估计孟加拉国三家医院流域范围内日本脑炎的发病率。
Am J Trop Med Hyg. 2011 Aug;85(2):379-85. doi: 10.4269/ajtmh.2011.10-0706.
8
Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009.2009 年中国分离的人类基因型 1 日本脑炎病毒及其遗传特征
PLoS One. 2011 Jan 25;6(1):e16418. doi: 10.1371/journal.pone.0016418.
9
Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China.中国四个城市的日本脑炎疾病负担和临床特征。
Am J Trop Med Hyg. 2010 Oct;83(4):766-73. doi: 10.4269/ajtmh.2010.09-0748.
10
Past, present, and future of Japanese encephalitis.日本脑炎的过去、现在与未来。
Emerg Infect Dis. 2009 Jan;15(1):1-7. doi: 10.3201/eid1501.080311.